Will sustained biological therapy improve long‑term outcome in inflammatory bowel disease?

Pol Arch Intern Med. 2022 Aug 22;132(7-8):16309. doi: 10.20452/pamw.16309. Epub 2022 Aug 22.

Authors

Pär Myrelid¹, Michael Eberhardson^{2

3}

Affiliations

¹ Department of Surgery, Linköping University Hospital and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. par.myrelid@liu.se
² Department of Gastroenterology and Hepatology, Linköping University Hospital and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
³ Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

PMID: 35993835
DOI: 10.20452/pamw.16309

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biological Therapy
Chronic Disease
Humans
Inflammatory Bowel Diseases* / drug therapy
Treatment Outcome